Abstract
MM has undergone a surge in novel therapies to treat the disease over the past decade. It is vital to educate patients on the common adverse effects of these new treatments, as well as the self-management strategies that can be implemented to maintain and promote their quality of life.
Sigma Membership
Unknown
Lead Author Affiliation
DePaul University, Chicago, Illinois, USA
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Multiple Myeloma, Adverse Effects, Self-Management Strategies
Recommended Citation
Cluster, Anndria D. and Tariman, Joseph D., "Common adverse effects of novel therapies for multiple myeloma (MM) and their self-management strategies" (2017). INRC (Congress). 397.
https://www.sigmarepository.org/inrc/2017/posters_2017/397
Conference Name
28th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Dublin, Ireland
Conference Year
2017
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Common adverse effects of novel therapies for multiple myeloma (MM) and their self-management strategies
Dublin, Ireland
MM has undergone a surge in novel therapies to treat the disease over the past decade. It is vital to educate patients on the common adverse effects of these new treatments, as well as the self-management strategies that can be implemented to maintain and promote their quality of life.